132 related articles for article (PubMed ID: 1735770)
1. Anti-GM1 IgA antibodies in Guillain-Barré syndrome.
Ilyas AA; Mithen FA; Chen ZW; Cook SD
J Neuroimmunol; 1992 Jan; 36(1):69-76. PubMed ID: 1735770
[TBL] [Abstract][Full Text] [Related]
2. [Association of IgA anti-GM1 antibody with antecedent diarrhea in patients with Guillain-Barré syndrome].
Koga M; Yuki N; Hirata K
Rinsho Shinkeigaku; 1997 Sep; 37(9):848-50. PubMed ID: 9431003
[TBL] [Abstract][Full Text] [Related]
3. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
[TBL] [Abstract][Full Text] [Related]
4. Guillain-Barré syndrome associated with high titers of anti-GM1 antibodies.
Nobile-Orazio E; Carpo M; Meucci N; Grassi MP; Capitani E; Sciacco M; Mangoni A; Scarlato G
J Neurol Sci; 1992 Jun; 109(2):200-6. PubMed ID: 1634903
[TBL] [Abstract][Full Text] [Related]
5. Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barré syndrome after Campylobacter jejuni enteritis.
Koga M; Yuki N; Hirata K
J Neuroimmunol; 1999 May; 96(2):245-50. PubMed ID: 10337924
[TBL] [Abstract][Full Text] [Related]
6. Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome.
Jacobs BC; van Doorn PA; Schmitz PI; Tio-Gillen AP; Herbrink P; Visser LH; Hooijkass H; van der Meché FG
Ann Neurol; 1996 Aug; 40(2):181-7. PubMed ID: 8773599
[TBL] [Abstract][Full Text] [Related]
7. Reactivity of serum IgG anti-GM1 ganglioside antibodies with the lipopolysaccharide fractions of Campylobacter jejuni isolates from patients with Guillain-Barre syndrome (GBS).
Gregson NA; Rees JH; Hughes RA
J Neuroimmunol; 1997 Mar; 73(1-2):28-36. PubMed ID: 9058756
[TBL] [Abstract][Full Text] [Related]
8. Anti-GM1 antibodies in patients with Guillain-Barré syndrome.
van den Berg LH; Marrink J; de Jager AE; de Jong HJ; van Imhoff GW; Latov N; Sadiq SA
J Neurol Neurosurg Psychiatry; 1992 Jan; 55(1):8-11. PubMed ID: 1548508
[TBL] [Abstract][Full Text] [Related]
9. Serum and CSF anti-GM1 antibodies in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
Simone IL; Annunziata P; Maimone D; Liguori M; Leante R; Livrea P
J Neurol Sci; 1993 Jan; 114(1):49-55. PubMed ID: 8433097
[TBL] [Abstract][Full Text] [Related]
10. Serum antibodies to GM1, GD1b, peripheral nerve myelin, and Campylobacter jejuni in patients with Guillain-Barré syndrome and controls: correlation and prognosis.
Vriesendorp FJ; Mishu B; Blaser MJ; Koski CL
Ann Neurol; 1993 Aug; 34(2):130-5. PubMed ID: 8338337
[TBL] [Abstract][Full Text] [Related]
11. Close association of Guillain-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1 alpha.
Yuki N; Tagawa Y; Irie F; Hirabayashi Y; Handa S
J Neuroimmunol; 1997 Apr; 74(1-2):30-4. PubMed ID: 9119976
[TBL] [Abstract][Full Text] [Related]
12. T cell-dependent activity of ganglioside GM1-specific B cells in Guillain-Barré syndrome and multifocal motor neuropathy in vitro.
Heidenreich F; Leifeld L; Jovin T
J Neuroimmunol; 1994 Jan; 49(1-2):97-108. PubMed ID: 8294565
[TBL] [Abstract][Full Text] [Related]
13. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
Oomes PG; Jacobs BC; Hazenberg MP; Bänffer JR; van der Meché FG
Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
[TBL] [Abstract][Full Text] [Related]
14. Affinity of anti-GM1 antibodies in Guillain-Barré syndrome patients.
Deisenhammer F; Keir G; Pfausler B; Thompson EJ
J Neuroimmunol; 1996 May; 66(1-2):85-93. PubMed ID: 8964918
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy.
Odaka M; Yuki N; Nobile-Orazio E; Carpo M; Hirata K
J Neurol Sci; 2000 Apr; 175(2):96-106. PubMed ID: 10831769
[TBL] [Abstract][Full Text] [Related]
16. Seroreactivity to Campylobacter jejuni and gangliosides in patients with Guillain-Barré syndrome.
von Wulffen H; Hartard C; Scharein E
J Infect Dis; 1994 Oct; 170(4):828-33. PubMed ID: 7930724
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to GT1a ganglioside in patients with Guillain-Barré syndrome.
Ilyas AA; Cook SD; Mithen FA; Taki T; Kasama T; Handa S; Hamasaki H; Singhal BS; Li SC; Li YT
J Neuroimmunol; 1998 Mar; 82(2):160-7. PubMed ID: 9585812
[TBL] [Abstract][Full Text] [Related]
18. Electrodiagnostic findings related to anti-GM1 and anti-GQ1b antibodies in Guillain-Barré syndrome.
Jacobs BC; Meulstee J; van Doorn PA; van der Meché FG
Muscle Nerve; 1997 Apr; 20(4):446-52. PubMed ID: 9121502
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal study of serum and cerebrospinal fluid (CSF) class-specific antibodies against Campylobacter jejuni and GM1 ganglioside in Guillain-Barré syndrome.
Kimura F; Ito T; Yuki N; Nakajima H; Tanaka T; Shinoda K; Ohsawa N
Intern Med; 1995 Oct; 34(10):1009-14. PubMed ID: 8563080
[TBL] [Abstract][Full Text] [Related]
20. GM 1 antibodies in Guillain-Barré syndrome: isotypes, course and clinical outcome.
Seiser A; Pötzl G; Safoschnik G; Pichler S; Bernheimer H; Schwerer B
Wien Klin Wochenschr; 1994; 106(6):159-63. PubMed ID: 8197746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
